| Document Date: 2014-01-09 16:15:33
Open Document File Size: 473,15 KBShare Result on Facebook
MedicalCondition tumor / Sarcoma / necrosis / Lung cancer / solid tumors / progressive disease / Trials Disease / patients progressive disease / Advanced HER2+ Cancer Recurrent/refractory / HER2+ Cancer HER2 / stable disease / / Organization TGFβ Dominant Negative Receptor / Trials / Results / and Challenges Investigator Institution / Administration of HER2 Chimeric Receptor / / Technology Dose Trial initiation date/status /enrollment PROTOCOL / /
SocialTag |
Synthetic Biology President’s Commission for the Study of Bioethical Issues 9 July 2010